Intra-Aortic Balloon Pumps

Intra-aortic balloon pumps have been used empirically for decades for cardiogenic shock in acute myocardial infarction and this study again finds no mortality benefit. They conclude: “IABP has no effect on all-cause mortality at 6-year long-term follow-up. Mortality is still very high, with two thirds of patients with cardiogenic shock dying despite contemporary treatment with revascularization therapy”.


The study and its implications are discussed further in an accompanying editorial link

Leave a Reply

Your email address will not be published. Required fields are marked *